Institutional Ownership
Cvrx Inc
CUSIP 126638105COMCVRXQ1 2026
13D / 13G Filings
19
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
19.6%
Max % of class reported
Institutional Holders
95
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
19 filings · latest Jan 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 12, 2026 | Johnson &Amp; Johnson | 13G/A | 15.4% | 4.02M | SEC |
| 2 | Feb 20, 2025 | New Enterprise Associates 10, Limited Partnership | 13D/A | 7.8% | — | SEC |
| 3 | Feb 6, 2025 | Cooperatieve Gilde Healthcare IV U.A. | 13D/A | 4.9% | — | SEC |
| 4 | Feb 6, 2025 | Vensana Capital I Gp, LLC | 13G/A | 11.0% | 1.76M | SEC |
| 5 | Nov 7, 2024 | New Enterprise Associates 10 L P | 13D/A | 9.3% | 2.25M | SEC |
| 6 | Nov 1, 2024 | Johnson & Johnson | 13G/A | 17.0% | 4.10M | SEC |
| 7 | Feb 6, 2024 | Vensana Capital I Gp, LLC | 13G/A | 8.2% | 1.71M | SEC |
| 8 | Feb 2, 2024 | Johnson & Johnson | 13G/A | 19.2% | 4.11M | SEC |
| 9 | Jan 19, 2024 | Cooperatieve Gilde Healthcare IV U.A. | 13D/A | 6.6% | 1.37M | SEC |
| 10 | Dec 29, 2023 | Cooperatieve Gilde Healthcare IV U.A. | 13D/A | 7.7% | 1.60M | SEC |
9 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cvrx Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Johnson & Johnson | 4.02M | $38.08M |
| 2 | Nea Management Company, LLC | 2.03M | $19.17M |
| 3 | Blackrock, Inc. | 1.03M | $9.71M |
| 4 | Gsk PLC | 1.01M | $9.53M |
| 5 | Royal Bank Of Canada | 707.0K | $6.69M |
| 6 | Balyasny Asset Management L.P. | 630.8K | $5.97M |
| 7 | Silvercrest Asset Management Group LLC | 572.0K | $5.41M |
| 8 | Parkman Healthcare Partners LLC | 429.5K | $4.06M |
| 9 | Geode Capital Management, LLC | 427.1K | $4.04M |
| 10 | State Street Corp | 350.5K | $3.32M |